Partner in Development for the Global Market
Pharmaceutical companies require reference listed drugs or Innovator drug when they create generic and biosimilar medications. We have a good network of validated suppliers across the EU, the US, Japan, S. Korea, etc. that can directly and safely procure pharmaceutical products from most major pharmaceutical companies.
This is a necessity in order to obtain approval from regulatory authorities such as the EMEA, the US FDA, or equivalent agencies in respective countries to make generic medication or biosimilars within a certain range of variation. Invimeds assists in securing highly specialized RLD and clinical trial material for such product development.
We also provide pharmaceutical businesses with a regulatory-compliant and cost-effective alternative for making medications available to patients in areas where their goods are not registered for sale and outside of clinical trial settings. This can occur when a drug is new and has not yet been licensed for marketing in the patient’s nation, or when a previously licensed medicine is no longer available. In any of these circumstances, InviMeds’ Managed Access Program may offer patients with timely and safe access to the medications they require.
Pharmaceutical company’s road to access and satisfy patient demand.
Due to a lack of resources and local market experience, many companies with products, particularly niche-segment or start-up pharmaceutical enterprises, are unable to enter Asian countries’ marketplaces. This is especially important for firms that make products for unregistered diseases. Patients are consequently denied access to new life-saving medications that are unavailable in their own country.
Through Named Patient Program in India and other emerging markets in the area, InviMeds offers its service to ease market entry in such nations. Although it may appear to be a simple matter, the importing process for unlicensed pharmaceuticals differs greatly between countries. Having an extensive understanding of the applicable procedures and regulations saves both money and time to market for InviMeds.
We may also assist corporations in licensing their product into a territory when the timing is perfect. InviMeds is ideally positioned to assist pharmaceutical and bio-pharmaceutical businesses with licensing their specialized medicines in India, should demand be high.